Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer

European Journal of Immunology

Volumn 44, Issue 12, 2014, Pages 3585-3595

  Langers, Inge ^a   Renoux, Virginie ^a,d   Reschner, Anca ^a   Touzé, Antoine ^b   Coursaget, Pierre ^b   Boniver, Jacques ^a   Koch, Joachim ^c   Delvenne, Philippe ^a   Jacobs, Nathalie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITÉ DE TOURS   (France)

^c INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Cell crosstalk; DC HPV vaccines; NK cells; Vaccination; Viral infection

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; WART VIRUS VACCINE; CANCER VACCINE; CD86 ANTIGEN; IFNG PROTEIN, HUMAN; INTERLEUKIN 12; KLRK1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K; VIRUS LIKE PARTICLE VACCINE;

ARTICLE; CANCER IMMUNIZATION; CELL MATURATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; TUMOR IMMUNITY; UPREGULATION; UTERINE CERVIX CANCER; VIRUS LIKE AGENT; CLINICAL TRIAL; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PATHOLOGY; UTERINE CERVICAL NEOPLASMS;

ANTIGENS, CD86; CANCER VACCINES; DENDRITIC CELLS; FEMALE; HLA-DR ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; UP-REGULATION; UTERINE CERVICAL NEOPLASMS; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84923632156     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444594     Document Type: Article

References (65)

1. Vacher, G., Kaeser, M. D., Moser, C., Gurny, R. and Borchard, G., Recent advances inmucosal immunization using virus-like particles. Mol. Pharm. 2013. 10: 1596-1609.
2. Paavonen, J., Jenkins, D., Bosch, F. X., Naud, P., Salmerón, J., Wheeler, C. M., Chow, S.-N. et al., Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 2007. 369: 2161-2170.
3. Barr, E. and Tamms, G., Quadrivalent human papillomavirus vaccine. Clin. Infect. Dis. 2007. 45: 609-607.
4. Ferlay, J., Shin, H. R., Bray, F., Forman, D., Mathers, C. and Parkin, D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer 2010. 127: 2893-2917.
5. Walboomers, J. M., Jacobs, M. V., Manos, M. M., Bosch, F. X., Kummer, J. A., Shah, K. V., Snijders, P. J. et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999. 189: 12-19.
6. Forman, D., de Martel, C., Lacey, C. J., Soerjomataram, I., Lortet-Tieulent, J., Bruni, L., Vignat, J. et al., Global burden of human papillomavirus and related diseases. Vaccine 2012. 30 Suppl.5: F12-23.
7. Zur Hausen, H., Papillomaviruses in the causation of human cancers-a brief historical account. Virology 2009. 384: 260-265.
8. Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T. et al., Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 2007. 298: 743-753.
9. Moretta, A., Bottino, C., Mingari, M. C., Biassoni, R. and Moretta, L., What is a natural killer cell? Nat. Immunol. 2002. 3: 6-8.
10. Langers, R., Thiry, D. and Jacobs, N., Natural killer cells: role in local tumor growth and metastasis. Biologics 2012. 73-82.
11. Renoux, V., Bisig, B., Langers, I., Dortu, E., Cléemenceau, B., Thiry, A., Deroanne, C. et al., Human papillomavirus entry into NK cells requires CD16 expression and triggers cytotoxic activity and cytokine secretion. Eur. J. Immunol. 2011. 44: 3240-3252.
12. Nagler, A., Lanier, L. L., Cwirla, S. and Phillips, J. H., Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 1989. 143: 3183-3191.
13. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E. et al., Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001. 97: 3146-3151.
14. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. et al., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
15. Rescigno, M. and Borrow, P., The host-pathogen interaction: new themes from dendritic cell biology. Cell 2001. 106: 267-270.
16. Kokhaei, P., Choudhury, A., Mahdian, R., Lundin, J., Moshfegh, A., Osterborg, A. and Mellstedt, H., Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. Leukemia 2004. 18: 1810-1815.
17. Lenz, P., Day, P. M., Pang, Y. Y., Frye, S. A., Jensen, P. N., Lowy, D. R. and Schiller, J. T., Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 2001. 166: 5346-5355.
18. García-Piñeres, A. J., Hildesheim, A., Trivett, M., Williams, M., Wu, L., Kewalramani, V. N. and Pinto, L. A., Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine. Eur. J. Immunol. 2006. 36: 437-445.
19. Fausch, S., Da Silva, D. and Kast, W., Differential uptake and crosspresentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res. 2003. 63: 3478-3482.
20. Altfeld, M., Fadda, L., Frleta, D. and Bhardwaj, N., DCs and NK cells: critical effectors in the immune response to HIV-1. Nat. Rev. Immunol. 2011. 11: 176-186.
21. Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G. and Trinchieri, G., Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 2002. 195: 327-333.
22. Le Cann, P., Coursaget, P., Iochmann, S. and Touze, A., Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol. Lett. 1994. 117: 269-274.
23. Bousarghin, L., Hubert, P., Franzen, E., Jacobs, N., Boniver, J. and Delvenne, P., Human papillomavirus 16 virus-like particles use heparan sulfates to bind dendritic cells and colocalize with langerin in Langerhans cells. J. Gen. Virol. 2005. 86: 1297-1305.
24. Piccioli, D., Sbrana, S., Melandri, E. and Valiante, N. M., Contactdependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 2002. 195: 335-341.
25. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M. and Münz, C., Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 2002. 195: 343-351.
26. Hartmann, J., Tran, T. V., Kaudeer, J., Oberle, K., Herrmann, J., Quagliano, I., Abel, T. et al., The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J. Biol. Chem. 2012. 287: 31527-31539.
27. van Kooten, C. and Banchereau, J., CD40-CD40 ligand. J. Leukoc. Biol. 2000. 67: 2-17.
28. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., Van Kooten, C., Durand, I. and Banchereau, J., Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 1994. 180: 1263-1272.
29. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A. and Alber, G., Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 1996. 184: 747-752.
30. Brilot, F., Strowig, T., Roberts, S. M., Arrey, F. and Munz, C., NK cell survival mediated through the regulatory synapse with human DCs requires IL-15Ralpha. J. Clin. Invest. 2007. 117: 3316-3329.
31. Barreira da Silva, R., Graf, C. and Munz, C., Cytoskeletal stabilization of inhibitory interactions in immunologic synapses of mature human dendritic cells with natural killer cells. Blood 2011. 118: 6487-6498.
32. Ferlazzo, G., Morandi, B., D'Agostino, A., Meazza, R., Melioli, G., Moretta, A. and Moretta, L., The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 2003. 33: 306-313.
33. Yan, M., Peng, J., Jabbar, I. A., Liu, X., Filgueira, L., Frazer, I. H. and Thomas, R., Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells. Virology 2004. 324: 297-310.
34. Fausch, S. C., Da Silva, D. M., Rudolf, M. P. and Kast, W. M., Human papillomavirus virus-like particles do not activate Langerhans cells: a possible immune escape mechanism used by human papillomaviruses. J. Immunol. 2002. 169: 3242-3249.
35. Evans, J. H., Horowitz, A., Mehrabi, M., Wise, E. L., Pease, J. E., Riley, E. M. and Davis, D. M., A distinct subset of human NK cells expressing HLA-DR expand in response to IL-2 and can aid immune responses to BCG. Eur. J. Immunol. 2011. 41: 1924-1933.
36. Draghi, M., Pashine, A., Sanjanwala, B., Gendzekhadze, K., Cantoni, C., Cosman, D., Moretta, A. et al., NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection. J. Immunol. 2007. 178: 2688-2698.
37. Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L. and Vivier, E., Naturalkiller cells and dendritic cells: "l'union fait la force". Blood 2005. 106: 2252-2258.
38. Mavilio, D., Lombardo, G., Kinter, A., Fogli, M., La Sala, A., Ortolano, S., Farschi, A. et al., Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J. Exp. Med. 2006. 203: 2339-2350.
39. Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Miyagi, T., Suzuki, T., Kanazawa, Y. et al., Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection. J. Immunol. 2004. 173: 6072-6081.
40. Mandaric, S., Walton, S. M., Rulicke, T., Richter, K., Girard-Madoux, M. J., Clausen, B. E., Zurunic, A. et al., IL-10 suppression of NK/DC crosstalk leads to poor priming ofMCMV-specific CD4 T cells and prolonged MCMV persistence. PLoS Pathog. 8: e1002846.
41. Giardino Torchia, M. L., Ciaglia, E., Masci, A. M., Vitiello, L., Fogli, M., la Sala, A., Mavilio, D. et al., Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors. PLoS ONE 2010. 5: e11052.
42. Buonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L. X., Kamin-Lewis, R., Abdelwahab, S. et al., Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses. J. Virol. 2006. 80: 9134-9143.
43. Warfield, K. L., Bosio, C. M., Welcher, B. C., Deal, E. M., Mohamadzadeh, M., Schmaljohn, A., Aman, M. J. et al., Ebola virus-like particles protect from lethal Ebola virus infection. Proc. Natl. Acad. Sci. USA 2003. 100: 15889-15894.
44. Barth, H., Ulsenheimer, A., Pape, G. R., Diepolder, H. M., Hoffmann, M., Neumann-Haefelin, C., Thimme, R. et al., Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. Blood 2005. 105: 3605-3614.
45. Hervas-Stubbs, S., Rueda, P., Lopez, L. and Leclerc, C., Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J. Immunol. 2007. 178: 2361-2369.
46. Lichtenegger, F. S., Mueller, K., Otte, B., Beck, B., Hiddemann, W., Schendel, D. J. and Subklewe, M., CD86 and IL-12p70 are key players for T Helper 1 polarization and natural killer cell activation by toll-like receptor-induced dendritic cells. PLoS ONE 2012. 7: e44266.
47. Corinti, S., Albanesi, C., la Sala, A., Pastore, S. and Girolomoni, G., Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 2001. 166: 4312-4318.
48. Jacobs, N., Giannini, S. L., Doyen, J., Baptista, A., Moutschen, M., Boniver, J. and Delvenne, P., Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin. Exp. Immunol. 1998. 111: 219-224.
49. Clerici, M., Merola, M., Ferrario, E., Trabattoni, D., Villa, M. L., Stefanon, B., Venzon, D. J. et al., Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J. Natl. Cancer Inst. 1997. 89: 245-250.
50. Jiao, L., Gao, X., Joyee, A. G., Zhao, L., Qiu, H., Yang, M., Fan, Y. et al., NK Cells Promote Type 1 T Cell Immunity through Modulating the Function of Dendritic Cells during Intracellular Bacterial Infection. J. Immunol. 2011. 187: 401-411.
51. Vitale, M., NK-dependent DC maturation is mediated by TNF and IFN released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566-571.
52. Marquez, M. E., Millet, C., Stekman, H., Conesa, A., Deglesne, P. A., Toro, F., Sanctis, J. D. et al., CD16 cross-linking induces increased expression of CD56 and production of IL-12 in peripheral NK cells. Cell. Immunol. 2010. 264: 86-92.
53. Greenstone, H. L., Nieland, J. D., de Visser, K. E., De Bruijn, M. L., Kirnbauer, R., Roden, R. B., Lowy, D. R. et al., Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model. Proc. Natl. Acad. Sci. USA. 1998. 95: 1800-1805.
54. Bourgault Villada, I., Moyal Barracco, M., Berville, S., Bafounta, M. L., Longvert, C., Préemel, V., Villefroy, P. et al., Human papillomavirus 16-specific T cell responses in classic HPV-related vulvar intra-epithelial neoplasia. Determination of strongly immunogenic regions from E6 and E7 proteins. Clin. Exp. Immunol. 2010. 159: 45-56.
55. Vitale, M., Della Chiesa, M., Carlomagno, S., Pende, D., Arico, M., Moretta, L. and Moretta, A., NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 2005. 106: 566-571.
56. Tewary, P., Yang, D., de la Rosa, G., Li, Y., Finn, M. W., Krensky, A. M., Clayberger, C. et al., Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 2010. 116: 3465-3474.
57. Pende, D., Expression of the DNAM-1 ligands, Nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 2006. 107: 2030-2036.
58. Pisegna, S., Zingoni, A., Pirozzi, G., Cinque, B., Cifone, M. G., Morrone, S., Piccoli, M. et al., Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells. J. Immunol. 2002. 169: 68-74.
59. Villalba, M., Bi, K., Hu, J., Altman, Y., Bushway, P., Reits, E., Neefjes, J. et al., Translocation of PKC[theta] in T cells is mediated by a nonconventional, PI3-K-and Vav-dependent pathway, but does not absolutely require phospholipase C. J. Cell Biol. 2002. 157: 253-263.
60. Yano, N., Endoh, M., Nomoto, Y., Sakai, H. and Rifai, A., Increase of HLADR-positive natural killer cells in peripheral blood from patients with IgA nephropathy. Hum. Immunol. 1996. 49: 64-70.
61. Colmenares, V., Noyola, D. E., Monsivais-Urenda, A., Salgado-Bustamante, M., Estrada-Capetillo, L., Gonzalez-Amaro, R. and Baranda, L., Human Papillomavirus Immunization Is Associated with Increased Expression of Different Innate Immune Regulatory Receptors. Clin. Vaccine Immunol. 2012. 19: 1005-1011.
62. Macedo, C., Turnquist, H. R., Castillo-Rama, M., Zahorchak, A. F., Shapiro, R., Thomson, A. W. and Metes, D., Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells. Am. J. Transplant. 2013. 13: 2322-2333.
63. Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B. et al., NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood 2004. 104: 3267-3275.
64. Jyothi, M. D. and Khar, A., Regulation of CD40L expression on natural killer cells by interleukin-12 and interferon gamma: its role in the elicitation of an effective antitumor immune response. Cancer Immunol. Immunother. 2000. 49: 563-572.
65. Jacobs, N., Greimers, R., Mazzoni, A., Trebak, M., Schaaf-Lafontaine, N., Boniver, J. and Moutschen, M. P., Further characterization of cytotoxic T cells generated by short-term culture of human peripheral blood lymphocytes with interleukin-2 and anti-CD3 mAb. Cancer Immunol. Immunother. 1996. 42: 369-375.